Fred M Powell
CIK 1331339 · Chief Financial Officer · last filed 2025-11-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
37
Lifetime Open-Market Net
$673.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LAVA Therapeutics NV (LVTX) Delisted | Chief Financial Officer | 0 | $1.74 | $0 | $0 | 2 | 2025-11-17 |
| ANTARES PHARMA, INC. (ATRS) Delisted | Executive Vice President & CFO | 791,036 | $5.59 | $4.42M | $612.5K | 17 | 2022-03-04 |
| Celator Pharmaceuticals Inc (CPXX) Delisted | VP and Chief Financial Officer | 0 | — | — | $46.3K | 10 | 2016-07-12 |
| BMP Sunstone CORP (BJGP) Delisted | Chief Financial Officer | 2,500 | — | — | $14.1K | 5 | 2009-08-17 |
Recent Filings · Page 2 of 4
37 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-06-15 | ANTARES PHARMA, INC. (ATRS) Delisted | Mixed | +123,304 | $336.2K | EDGAR |
| 2020-06-09 | ANTARES PHARMA, INC. (ATRS) Delisted | Tax (F) | −18,292 | -$57.2K | EDGAR |
| 2020-02-21 | ANTARES PHARMA, INC. (ATRS) Delisted | Mixed | +39,443 | -$84.0K | EDGAR |
| 2019-06-14 | ANTARES PHARMA, INC. (ATRS) Delisted | Grant (A) | +90,411 | $264.0K | EDGAR |
| 2019-06-11 | ANTARES PHARMA, INC. (ATRS) Delisted | Tax (F) | −18,293 | -$51.4K | EDGAR |
| 2018-06-11 | ANTARES PHARMA, INC. (ATRS) Delisted | Mixed | +82,058 | $221.6K | EDGAR |
| 2017-06-13 | ANTARES PHARMA, INC. (ATRS) Delisted | Buy (P) | +130,000 | $363.3K | EDGAR |
| 2017-06-09 | ANTARES PHARMA, INC. (ATRS) Delisted | Grant (A) | +101,434 | $269.8K | EDGAR |
| 2016-12-12 | ANTARES PHARMA, INC. (ATRS) Delisted | Buy (P) | +100,000 | $202.5K | EDGAR |
| 2016-11-02 | ANTARES PHARMA, INC. (ATRS) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.